Catherine Prescott

Catherine Prescott

Directeur/Bestuurslid bij SKINBIOTHERAPEUTICS PLC

Vermogen: 13 575 $ op 30-04-2024

Health Technology
Finance
Commercial Services

Oorsprong van het eerstegraads netwerk van Catherine Prescott

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Other 9
6
Holding Company Packaged Software 6

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Catherine Prescott via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Internet Software/Services

Matthew MacKowski

Jeanette Welsh

Ravi Nalliah

Chairman

Director/Board Member

Director/Board Member

Investment Managers

Matthew MacKowski

Jeanette Welsh

Chairman

Chief Operating Officer

Medical/Nursing Services

Fiona Withey

Ravi Nalliah

Chief Executive Officer

Director of Finance/CFO

Medical Specialties

Stuart Ashman

Manprit Randhawa

Chief Executive Officer

Director of Finance/CFO

Medical Specialties

Matthew MacKowski

Jeanette Welsh

Director/Board Member

Director/Board Member

Biotechnology

Martin Hunt

Douglas Quinn

Chairman

Director of Finance/CFO

Biotechnology

Stephen O'Hara

Founder

Pharmaceuticals: Other

Stephen O'Hara

Founder

Probiotix Ltd.

Stephen O'Hara

Founder

3M COMPANY Medical Specialties

Stephen O'Hara

Corporate Officer/Principal

Medical/Nursing Services

Stephen O'Hara

Director/Board Member

TI Group Ltd. Miscellaneous

Stuart Ashman

Chief Executive Officer

Medical/Nursing Services

Stephen O'Hara

Corporate Officer/Principal

OPTIBIOTIX HEALTH PLC Biotechnology

Stephen O'Hara

Founder

University of Cardiff College/University

Ravi Nalliah

Undergraduate Degree

University of Wales (Bangor) College/University

Fiona Withey

Doctorate Degree

Medical Specialties

Stuart Ashman

Chief Executive Officer

SMITH & NEPHEW PLC Medical Specialties

Stuart Ashman

Sales & Marketing

Medical Distributors

Stuart Ashman

Sales & Marketing

Financial Conglomerates

Manprit Randhawa

Director/Board Member

KROMEK GROUP PLC Medical Specialties

Manprit Randhawa

Director of Finance/CFO

Information Technology Services

Manprit Randhawa

Director/Board Member

Packaged Software

Manprit Randhawa

Director/Board Member

Packaged Software

Manprit Randhawa

Director/Board Member

Packaged Software

Manprit Randhawa

Director/Board Member

Packaged Software

Manprit Randhawa

Director/Board Member

Packaged Software

Manprit Randhawa

Director/Board Member

Leeds Trinity University College College/University

Douglas Quinn

Graduate Degree

Packaged Software

Manprit Randhawa

Director/Board Member

The University of Wales College/University

Philip John Roberts

Undergraduate Degree

Investment Managers

Philip John Roberts

Founder

Industrial Machinery

Philip John Roberts

Director/Board Member

Miscellaneous Manufacturing

Philip John Roberts

Director/Board Member

Other Transportation

Philip John Roberts

Director/Board Member

Curapel Ltd.

Catherine O'Neill

Founder

Investment Managers

Douglas Quinn

Private Equity Investor

Investment Managers

Douglas Quinn

Private Equity Investor

Information Technology Services

Douglas Quinn

Director of Finance/CFO

Medical Specialties

Matthew MacKowski

Chairman

Miscellaneous Commercial Services

Martin Hunt

Director/Board Member

Regentix Ltd.

Martin Hunt

Director/Board Member

Tissue Science Laboratories (UK) Ltd.

Martin Hunt

Director/Board Member

Medical Specialties

Martin Hunt

Chief Executive Officer

ALPHA TEKNOVA, INC. Pharmaceuticals: Major

Matthew MacKowski

Director/Board Member

Medical Specialties

Matthew MacKowski

Director/Board Member

Chemicals: Agricultural

Martin Hunt

Corporate Officer/Principal

Statistieken

Internationaal

Verenigd Koninkrijk 41
Verenigde Staten 9
Finland 2
Ierland 2

Sectoraal

Health Technology 15
Technology Services 10
Finance 7
Consumer Services 5
Health Services 4

Operationeel

Director/Board Member 46
Corporate Officer/Principal 15
Chief Executive Officer 13
Director of Finance/CFO 11
Founder 9
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU